0,989  0,002  Respiratory analeptic
0,963  0,002  Analeptic
0,925  0,005  Apoptosis agonist
0,891  0,005  Antineoplastic (breast cancer)
0,879  0,005  Antineoplastic (lung cancer)
0,871  0,008  Transcription factor NF kappa B inhibitor
0,851  0,004  Antineoplastic (ovarian cancer)
0,842  0,004  Cardiotonic
0,815  0,005  Prostate cancer treatment
0,791  0,003  Anesthetic
0,787  0,004  Cytotoxic
0,774  0,006  Chemopreventive
0,765  0,009  Antineoplastic (colorectal cancer)
0,756  0,005  Antineoplastic (cervical cancer)
0,749  0,010  Antineoplastic (colon cancer)
0,737  0,005  NOS2 expression inhibitor
0,731  0,005  Antineoplastic (melanoma)
0,740  0,024  Antiinflammatory
0,714  0,005  Antineoplastic (glioma)
0,693  0,004  Muscle relaxant
0,678  0,005  Heart failure treatment
0,654  0,004  Diuretic
0,633  0,009  NOS3 expression inhibitor
0,615  0,009  Nitric oxide antagonist
0,615  0,009  Antineoplastic (pancreatic cancer)
0,626  0,021  Antileukemic
0,624  0,022  Teratogen
0,605  0,007  Hypoxia-inducible factor 1 alpha inhibitor
0,620  0,027  CYP3A4 substrate
0,588  0,004  Skeletal muscle relaxant
0,581  0,013  Hepatic disorders treatment
0,569  0,004  Contraceptive
0,563  0,000  Na+ K+ transporting ATPase inhibitor
0,560  0,004  Interleukin 6 antagonist
0,553  0,005  Transcription factor STAT3 inhibitor
0,552  0,005  UGT2B4 substrate
0,554  0,026  Embryotoxic
0,528  0,006  Transcription factor STAT inhibitor
0,517  0,008  UGT1A4 substrate
0,508  0,009  Antineoplastic (liver cancer)
0,508  0,013  Antineoplastic (glioblastoma multiforme)
0,520  0,028  Immunosuppressant
0,516  0,025  Bone diseases treatment
0,509  0,019  Antiosteoporotic
0,498  0,010  UGT1A1 substrate
0,505  0,020  AR expression inhibitor
0,486  0,010  Antineoplastic (renal cancer)
0,489  0,014  ICAM1 expression inhibitor
0,465  0,005  Lipocortins synthesis antagonist
0,460  0,004  UGT2B9 substrate
0,452  0,003  Mineralocorticoid receptor antagonist
0,483  0,040  CYP2C9 substrate
0,449  0,008  Sodium/bile acid cotransporter inhibitor
0,469  0,030  Antihypercholesterolemic
0,451  0,015  UDP-glucuronosyltransferase substrate
0,435  0,004  Postmenopausal disorders treatment
0,454  0,027  Carcinogenic
0,478  0,053  TNF expression inhibitor
0,428  0,007  UGT2B15 substrate
0,453  0,040  Cholesterol antagonist
0,431  0,020  UGT1A6 substrate
0,418  0,009  UGT2B7 substrate
0,421  0,014  P-glycoprotein inhibitor
0,417  0,012  Hepatoprotectant
0,438  0,035  Antifungal
0,410  0,010  Prostate disorders treatment
0,407  0,011  UGT1A3 substrate
0,423  0,032  Apoptosis antagonist
0,414  0,027  Proliferative diseases treatment
0,397  0,016  Antineoplastic (sarcoma)
0,396  0,017  Abortion inducer
0,409  0,032  Cytostatic
0,390  0,023  Vascular (periferal) disease treatment
0,414  0,061  Antipruritic, allergic
0,384  0,038  Antioxidant
0,420  0,080  Cyclophilin D inhibitor
0,420  0,080  Antidiabetic
0,381  0,047  Antihypertensive
0,373  0,046  Lipoprotein disorders treatment
0,398  0,078  Antibacterial
0,325  0,005  Aromatase inhibitor
0,318  0,010  Sulfotransferase substrate
0,325  0,019  Prostatic (benign) hyperplasia treatment
0,346  0,053  Antineoplastic (brain cancer)
0,340  0,049  UGT1A9 substrate
0,336  0,046  Sensitization
0,335  0,048  Chemoprotective
0,297  0,023  Antiacne
0,313  0,047  Antineoplastic (lymphoma)
0,303  0,048  Hypolipemic
0,280  0,026  Antipruritic, non-allergic
0,251  0,004  Androgen agonist
0,310  0,067  Interleukin 2 agonist
0,254  0,012  UGT2B10 substrate
0,242  0,013  Farnesoid X receptor antagonist
0,237  0,010  Androgen antagonist
0,232  0,011  Arachidonic acid antagonist
0,238  0,019  VEGF expression inhibitor
0,236  0,020  Antiviral (Hepatitis B)
0,227  0,014  Microtubule formation inhibitor
0,223  0,010  Contraceptive female
0,263  0,066  Cardiovascular analeptic
0,241  0,044  Neurotrophic factor enhancer
0,246  0,055  Mutagenic
0,223  0,034  Antiviral (Influenza A)
0,215  0,026  Antifungal enhancer
0,249  0,062  Interleukin antagonist
0,212  0,037  Interferon gamma antagonist
0,201  0,026  Cholesterol synthesis inhibitor
0,260  0,086  Radioprotector
0,214  0,041  Urolithiasis treatment
0,259  0,090  Antihypoxic
0,189  0,023  Antineoplastic antibiotic
0,174  0,010  SULT1E1 substrate
0,170  0,009  UGT2B11 substrate
0,204  0,043  Hair growth stimulant
0,178  0,022  Choleretic
0,258  0,102  CTGF expression inhibitor
0,159  0,008  Premenstrual syndrome treatment
0,162  0,012  Anabolic
0,246  0,098  Immunostimulant
0,233  0,086  Antineoplastic (non-small cell lung cancer)
0,320  0,173  Caspase 9 stimulant
0,168  0,023  UGT2B1 substrate
0,237  0,101  CYP2C19 substrate
0,227  0,095  DNA damaging
0,216  0,086  Angiogenesis stimulant
0,243  0,118  Caspase 3 stimulant
0,141  0,020  ABCA1 expression enhancer
0,216  0,099  DNA synthesis inhibitor
0,194  0,078  Anesthetic general
0,156  0,046  DNA polymerase I inhibitor
0,167  0,057  Protein kinase stimulant
0,171  0,062  Protein-tyrosine phosphatase inhibitor
0,168  0,061  Melanin inhibitor
0,120  0,014  Estrogen agonist
0,164  0,058  Amylase inhibitor
0,144  0,038  Alcohol dehydrogenase substrate
0,187  0,083  Antiviral (Influenza)
0,109  0,005  RNA-directed RNA polymerase stimulant
0,149  0,046  Protein-tyrosine phosphatase 1B inhibitor
0,251  0,149  Antineoplastic (endocrine cancer)
0,132  0,033  Toll-Like receptor 4 antagonist
0,134  0,034  Estrogen antagonist
0,152  0,054  Carcinogenic, group 3
0,128  0,034  Hedgehog signaling inhibitor
0,104  0,011  Estrogen receptor beta agonist
0,175  0,082  Antiviral (Hepatitis)
0,219  0,126  CYP2D6 substrate
0,221  0,127  CYP1A2 substrate
0,114  0,022  Glycine receptor antagonist
0,189  0,097  Antialcoholic
0,097  0,009  Estrogen receptor alpha agonist
0,091  0,004  Progesterone agonist
0,149  0,065  Antineoplastic (squamous cell carcinoma)
0,136  0,053  Growth stimulant
0,118  0,035  Estrogen receptor beta antagonist
0,090  0,008  Lipocortins synthesis agonist
0,207  0,125  Cardioprotectant
0,098  0,019  Anticholelithogenic
0,153  0,076  Antiviral (Herpes)
0,085  0,010  Aldosterone antagonist
0,136  0,065  Skin whitener
0,133  0,065  Antihemorrhagic
0,101  0,035  Contraceptive male
0,120  0,054  Glutathione S-transferase substrate
0,157  0,094  Phospholipase C inhibitor
0,066  0,005  Glucose-6-phosphate dehydrogenase inhibitor
0,064  0,010  Glucocorticoid antagonist
0,098  0,048  Antineoplastic alkaloid
0,083  0,034  Glycine receptor agonist
0,062  0,014  Progesterone antagonist
0,070  0,022  Postcoital contraceptive
0,135  0,090  NOS3 expression enhancer
0,060  0,015  Microtubule stabilization
0,152  0,108  Toxic, respiratory center
0,190  0,146  Renal disease treatment
0,075  0,033  SULT2A1 substrate
0,078  0,046  CDC25A inhibitor
0,079  0,047  Antibiotic
0,049  0,019  5-Alpha-reductase inhibitor
0,041  0,014  Tubulin agonist
0,160  0,134  Free radical scavenger
0,092  0,068  Bile acid receptor antagonist
0,144  0,120  LDLR expression enhancer
0,044  0,024  Hypogonadism treatment
0,057  0,038  Acetyl-CoA transferase 2 inhibitor
0,053  0,037  Protein 50S ribosomal subunit inhibitor
0,097  0,084  SULT1A1 substrate
0,060  0,047  Heme oxygenase stimulant
0,166  0,154  Hypoglycemic
0,035  0,023  HMG CoA reductase inhibitor
0,023  0,012  Corticosteroid-like
0,161  0,150  VCAM1 expression inhibitor
0,192  0,183  CYP3A4 inhibitor
0,039  0,032  Estradiol 17 beta-dehydrogenase inhibitor
0,017  0,011  Telomerase stimulant
0,099  0,095  Interleukin 2 antagonist
0,039  0,035  Cholesterol absorption inhibitor
0,042  0,040  Parathyroid hormone antagonist

